Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IMMUNOTHERAPY”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07033663
What this trial is testing

Impact of In Utero Exposure to Immunomodulatory Drugs on Neonatal Immune System Development

Who this might be right for
Pregnancy RelatedImmune-mediated Diseases
Fundació Sant Joan de Déu 90
Early research (Phase 1)WithdrawnNCT03807063
What this trial is testing

Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant

Who this might be right for
Acute Bilineal LeukemiaMyelodysplastic/Myeloproliferative NeoplasmMyelodysplastic/Myeloproliferative Neoplasm, Unclassifiable+9 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Active Not RecruitingNCT02935257
What this trial is testing

Immunotherapy for High Risk/Relapsed CD19+ Acute Lymphoblastic Leukaemia, B-cell Non-Hodgkin's Lymphoma (B-NHL) and Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) Using CAR T-cells to Target CD19

Who this might be right for
Leukemia, Lymphoblastic, Acute, Lymphoma
University College, London 72
Testing effectiveness (Phase 2)UnknownNCT04586088
What this trial is testing

Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failure

Who this might be right for
Nasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma+3 more
Sun Yat-sen University 58
Testing effectiveness (Phase 2)Looking for participantsNCT07617246
What this trial is testing

The Efficacy and Safety of Fosrolapitant and Palonosetron Hydrochloride for Injection in Preventing Nausea and Vomiting Caused by Multi-cycle Immunotherapy and Chemotherapy in Patients With Esophageal Cancer and Lung Cancer

Who this might be right for
Esophagus CancerLung Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 120
Testing effectiveness (Phase 2)UnknownNCT02862561
What this trial is testing

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer

Who this might be right for
Precision Cell ImmunotherapyChemotherapyAdvanced Malignancies
Shanghai International Medical Center 40
Large-scale testing (Phase 3)Study completedNCT05254561
What this trial is testing

Triple Antigen vs Monoantigen Immunotherapy for Warts

Who this might be right for
Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts
Zagazig University 160
Large-scale testing (Phase 3)Looking for participantsNCT07002346
What this trial is testing

INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma

Who this might be right for
Ovarian Clear Cell Carcinoma
Tongji Hospital 226
Very early researchUnknownNCT05812677
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer

Who this might be right for
Cervical CancerEndometrial CancerAdvanced Cancer
Shanghai Yunying Medical Technology 20
Testing effectiveness (Phase 2)UnknownNCT01354457
What this trial is testing

Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+

Who this might be right for
Acute Lymphoblastic Leukemia
Nantes University Hospital 21
Not applicableUnknownNCT06309862
What this trial is testing

Immune Checkpoint Inhibitor Therapy for Cancer and Risk of Myocarditis or Cardiomyopathy

Who this might be right for
Cardio-OncologyCardiomyopathy Due to Drug
Sunnybrook Health Sciences Centre 15
Testing effectiveness (Phase 2)Study completedNCT07671495
What this trial is testing

Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin

Who this might be right for
Melanoma Stage IMelanoma Stage IIIMelanoma Stage II+1 more
MIPO Clinic 278
Testing effectiveness (Phase 2)UnknownNCT02638857
What this trial is testing

Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Recurrence Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma
Second Military Medical University 60
Not applicableStudy completedNCT03375775
What this trial is testing

Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children

Who this might be right for
Rhinitis, AllergicConjunctivitis, AllergicAsthma
Karolinska Institutet 40
Testing effectiveness (Phase 2)UnknownNCT05981157
What this trial is testing

Anrotinib and Tirelizumab in First-line Treatment of RM-NPC

Who this might be right for
Nasopharyngeal Carcinoma
Zhongshan People's Hospital, Guangdong, China 27
Early research (Phase 1)Active Not RecruitingNCT05782361
What this trial is testing

POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC

Who this might be right for
Advanced CancerNon Small Cell Lung Cancer
Institute of Cancer Research, United Kingdom 19
Not applicableUnknownNCT05633641
What this trial is testing

Peripheral Blood Neoantigen Specific T Cells Predict the Efficacy of Immunotherapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 60
Large-scale testing (Phase 3)Looking for participantsNCT06229041
What this trial is testing

Total Neoadjuvant Treatment ±Immunotherapy for High Risk Locally Advanced Rectal Cancer (TNTi)

Who this might be right for
Rectal Cancer
Peking University Cancer Hospital & Institute 472
Testing effectiveness (Phase 2)UnknownNCT05173441
What this trial is testing

Human COVID-19 Immunoglobulin (COVID-HIG) Therapy for COVID-19 Patients

Who this might be right for
COVID-19
Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd. 180
Early research (Phase 1)Study completedNCT00112242
What this trial is testing

Immunotherapy of Stage III/IV Melanoma Patients

Who this might be right for
Melanoma
Centre Hospitalier Universitaire Vaudois 39
Next Page